摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 1-(prop-2-yn-1-yl)cyclopentanecarboxylate | 1075217-13-8

中文名称
——
中文别名
——
英文名称
methyl 1-(prop-2-yn-1-yl)cyclopentanecarboxylate
英文别名
methyl 1-(prop-2-ynyl) cyclopentanecarboxylate;Methyl 1-(prop-2-yn-1-yl)cyclopentane-1-carboxylate;methyl 1-prop-2-ynylcyclopentane-1-carboxylate
methyl 1-(prop-2-yn-1-yl)cyclopentanecarboxylate化学式
CAS
1075217-13-8
化学式
C10H14O2
mdl
——
分子量
166.22
InChiKey
BAAVOECYIVYZLI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 1-(prop-2-yn-1-yl)cyclopentanecarboxylate 在 lithium aluminium tetrahydride 作用下, 以 乙醚 为溶剂, 反应 12.0h, 生成 (1-(prop-2-yn-1-yl)cyclopentyl)methanol
    参考文献:
    名称:
    A silver-promoted auto-tandem catalysis for the synthesis of multiply substituted tetrahydrocarbazoles
    摘要:
    三氟甲磺酸银高效催化炔烃醛与吲哚的串联反应,以高产率生成高度取代的四氢咔唑。
    DOI:
    10.1039/c0cc04383d
  • 作为产物:
    描述:
    参考文献:
    名称:
    在温热条件下,通过复杂的级联反应,由氯代硫酸盐合成磺酸盐。
    摘要:
    氯硫酸盐衍生物是令人感兴趣的试剂,传统上已用于通过氯原子的形式亲核取代获得其他含硫化合物。这项工作描述了含炔的氯代硫酸盐得到磺内酯(内酯的硫类似物)的不同反应方式。在这种转化过程中观察到的复杂骨架重排与有机金属化合物促进或催化的复杂过程相当。然而,这里描述的反应不需要任何试剂或添加剂,仅是热处理。计算计算支持一种基于一系列级联反应的机制,其中几乎每个步骤都是违反直觉的。其中一些步骤包括与经典反应相关的原始过程,
    DOI:
    10.1002/chem.201903228
点击查看最新优质反应信息

文献信息

  • [EN] PROTEIN KINASE C AGONISTS<br/>[FR] AGONISTES DE PROTÉINE KINASE C
    申请人:GILEAD SCIENCES INC
    公开号:WO2020176505A1
    公开(公告)日:2020-09-03
    The present disclosure relates generally to certain diacylglycerol lactone compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or prevention of diseases, disorders, or infections modifiable by protein kinase C (PKC) agonists, such as HIV.
    本公开涉及某些二酰基甘油内酯化合物,包括该化合物的药物组合物,以及制备和使用该化合物和药物组合物的方法。本文所披露的化合物和组合物可用于治疗或预防可通过蛋白激酶C(PKC)激动剂调节的疾病、疾病或感染,如艾滋病。
  • Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme
    申请人:Liu Gang
    公开号:US20080293713A1
    公开(公告)日:2008-11-27
    The present invention relates to compounds of formula (I): wherein R 1 , R 2 , and R 3 , are defined herein. Pharmaceutical compositions and methods for treating DGAT- 1 related diseases or conditions are also disclosed.
    本发明涉及式(I)的化合物,其中R1、R2和R3在此定义。还公开了治疗DGAT-1相关疾病或病状的药物组合物和方法。
  • INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME
    申请人:Liu Gang
    公开号:US20120041003A1
    公开(公告)日:2012-02-16
    The present invention relates to compounds of formula (I): wherein R 1 , R 2 , and R 3 , are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.
    本发明涉及式(I)的化合物:其中R1,R2和R3在此定义。还公开了治疗DGAT-1相关疾病或病状的药物组合物和方法。
  • Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
    申请人:Abbott Laboratories
    公开号:EP2500347A1
    公开(公告)日:2012-09-19
    The present invention relates to compounds of formula (I): wherein R1, R2, and R3, are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.
    本发明涉及式(I)化合物:其中 R1、R2 和 R3 在此定义。还公开了治疗 DGAT-1 相关疾病或病症的药物组合物和方法。
  • Au(I)-Catalyzed Cascade Reaction Involving Formal Double Hydroamination of Alkynes Bearing Tethered Carboxylic Groups: An Easy Access to Fused Dihydrobenzimidazoles and Tetrahydroquinazolines
    作者:Nitin T. Patil、Anil Kumar Mutyala、Pediredla G. V. V. Lakshmi、Balakrishna Gajula、Balasubramanian Sridhar、Gurava Reddy Pottireddygari、Tadikamalla Prabhakar Rao
    DOI:10.1021/jo1013228
    日期:2010.9.3
    A process involving gold(I)-catalyzed formal double hydroamination of alkynes, bearing a tethered carboxylic group, for the synthesis of fused dihydrobenzimidazoles and tetrahydroquinazolines has been developed. A series of transition metal catalysts have been screened for this transformation, and a catalyst system consisting of Ph3PAuCl (1 mol %) and AgOTf (1 mol %) was found to be the best. The procedure entails the reaction of easily accessible starting materials such as alkynoic acids and 1,2-diaminobenzenes/2-aminobenzylamines in the presence of the catalyst in 1,2-dichloroethane at 100 degrees C. In the case of alpha-substituted alkynoic acids, the corresponding products were obtained in high diastereoselectivities; the structure of the diastereomers has been unambiguously characterized by NMR techniques. The mechanism of the reaction is discussed, and the origin of the diastereoselectivities is addressed. It was observed that under the microwave irradiation conditions, the reaction time is significantly shortened (0.5 h).
查看更多